IVRN.US Innoveren Scientific Inc.

Healthcare Biotechnology USA Stocks
0.0004 USD
Close of Nov 14, 2026
0.0002 0.0007
Market cap
USD 1.86K
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Is IVRN.US undervalued?

Graham number

The Graham number of Innoveren Scientific Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Innoveren Scientific Inc. fundamental analysis

No fundamental analysis for Innoveren Scientific Inc. yet.

Innoveren Scientific Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Innoveren Scientific Inc.

Innoveren Scientific Inc., a medical bioscience company that develops technology in regenerative medicine for limb salvage. It is also developing immunotherapies for ovarian cancer, pancreatic cancer, and mesothelioma. The company was formerly known as H-CYTE, Inc. and changed its name to Innoveren Scientific Inc. in July 2023. The company is based in Cincinnati, Ohio.

Full company profile